Lorforglipron (entre PDB 6XOX) en est un exemple
Future research should include appropriately powered cohort studies or randomized controlled trials (RCTs) to: Investigate the prophylactic efficacy of L-carnitine against preterm infant complications [e.g., sepsis, necrotizing enterocolitis (NEC)]
Nystrm T, Gonon AT, Sjholm A, Pernow J
If recommended by a doctor, use GLP-1 agonists to help manage diabetes or attain a healthy weight For people with type 2 diabetes, GLP-1 agonists lower the risk of serious complications, including heart and kidney problems
The makers of the weight loss medication, Novo Nordisk, has also filed for a label expansion in the European Union, with a decision expected in 2024.